Int J Heart Fail.
2019 Oct;1(1):69-71. 10.36628/ijhf.2019.0008.
Eligibility and Usage of Sacubitril/ Valsartan in Korea
- Affiliations
-
- 1Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
- KMID: 2532593
- DOI: http://doi.org/10.36628/ijhf.2019.0008
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
- Real-World Usage of Sacubitril/ Valsartan in Korea: A Multi-Center, Retrospective Study
- ECG Monitoring of Reactions to Sacubitril-valsartan in Heart Failure with Reduced Ejection Fraction
- Angiotensin receptor-neprilysin inhibitor for the treatment of heart failure: a review of recent evidence
- Real-World Eligibility for Sacubitril/ Valsartan in Heart Failure with Reduced Ejection Fraction Patients in Korea: Data from the Korean Acute Heart Failure (KorAHF) Registry
